Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V-INTERVENTION: Inclisiran for Prevention of Cardiovascular and Limb Events After Revascularization
NCT06909565Phase 4Recruiting
- Sponsor
- Duke University
- Start
- Jul 2025
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
A Phase 4 trial of inclisiran in atherosclerotic cardiovascular disease (ASCVD), sponsored by Duke University. Started Jul 2025; status: recruiting.
02
Drugs
inclisiran
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT06909565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06909565.